Paresh Dandona, MD
SUNY Buffalo · SUNY at Buffalo · Distinguished Professor of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paresh Dandona, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:28 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05609604 · Role of Transcranial Direct Current Stimulation in Appetite and Weight ControlUniversity at Buffalo · terminated · Weight Loss, Appetite Loss · principal investigator
- Ph3NCT05098327 · Pioglitazone and Insulin Resistance in ADTState University of New York at Buffalo · withdrawn · Prostate Cancer, Insulin Resistance, Diabetes Mellitus, Type 2 · principal investigator
- Ph4NCT04638400 · Anti-inflammatory Effects of Simvastatinparesh Dandona · terminated · Inflammation, Atherosclerosis, Hypercholesterolemia · principal investigator
- Ph4NCT02433678 · An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of DapagliflozinUniversity at Buffalo · completed · Type 2 Diabetes · principal investigator
- N/ANCT01741103 · Sitagliptin in Type I Diabetic PatientsUniversity at Buffalo · withdrawn · Diabetes Type I · principal investigator
- N/ANCT01420328 · To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese SubjectsUniversity at Buffalo · completed · Inflammation · principal investigator
- Ph4NCT01161394 · Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging StudyUniversity at Buffalo · completed · Inflammation · principal investigator
- N/ANCT01158417 · Resveratrol in Type2 Diabetes and ObesityUniversity at Buffalo · terminated · Type 2 Diabetes, Obesity, Insulin Resistance · principal investigator
- N/ANCT00659711 · The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic SubjectsUniversity at Buffalo · completed · Type 2 Diabetes · principal investigator
- Ph4NCT00430040 · Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.University at Buffalo · terminated · Diabetes Mellitus, Type 2, Hypertension · principal investigator
- Ph4NCT00350701 · Effect of Androgel on Type 2 Diabetic Males With HypogonadismUniversity at Buffalo · completed · Diabetes Mellitus Type 2 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- University of Buffalo Clinical and Translational Science InstituteUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Timothy F Murphy · fiscal years 2015 to 2024Named on NCT05098327
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.